PMCB
PharmaCyte Biotech·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
4.39 / 10Overall Score
NeturalInvestment Rating
4.39 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of PMCB
- Based on a composite score of 4.39/10, we rate PMCB as a Netural. Our analysis breaks down into 4.83/10 for Fundamentals, 1.42/10 for Technicals, and 6.93/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of PMCB?
Is PMCB undervalued or overvalued?
Is money flowing into or out of PMCB?
Trend Analysis of PMCB
- Based on a composite score of 4.39/10, we rate PMCB as a Netural. Our analysis breaks down into 4.83/10 for Fundamentals, 1.42/10 for Technicals, and 6.93/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is PMCB undervalued or overvalued?
Technical Analysis of PMCB?
Is money flowing into or out of PMCB?
